690
Views
30
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Effect of Inhaled Corticosteroids on the Development of Emphysema in Smokers Assessed by Annual Computed Tomography

, , , , , , , , , , , & show all
Pages 104-111 | Published online: 02 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Gaetano Caramori, Paolo Ruggeri, Fabio Arpinelli, Laura Salvi & Giuseppe Girbino. (2019) Long-term use of inhaled glucocorticoids in patients with stable chronic obstructive pulmonary disease and risk of bone fractures: a narrative review of the literature. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1085-1097.
Read now
Rob Janssen, Ianthe Piscaer, Frits M. E. Franssen & Emiel F. M. Wouters. (2019) Emphysema: looking beyond alpha-1 antitrypsin deficiency. Expert Review of Respiratory Medicine 13:4, pages 381-397.
Read now
Diana Crossley, Mary Renton, Muhammad Khan, Emma V Low & Alice M Turner. (2018) CT densitometry in emphysema: a systematic review of its clinical utility. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 547-563.
Read now
Sally Hollis, Carin Jorup, Dan Lythgoe, Gunnar Martensson, Pontus Regnell & Göran Eckerwall. (2017) Risk of pneumonia with budesonide-containing treatments in COPD: an individual patient-level pooled analysis of interventional studies. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1071-1084.
Read now
Saher B. Shaker, Trine Stavngaard, Lars Christian Laursen, Berend C. Stoel & Asger Dirksen. (2011) Rapid Fall in Lung Density Following Smoking Cessation in COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease 8:1, pages 2-7.
Read now

Articles from other publishers (25)

Ian A Yang, Olivia R Ferry, Melissa S Clarke, Esther HA Sim & Kwun M Fong. (2023) Inhaled corticosteroids versus placebo  for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2023:3.
Crossref
Won-Dong Kim. (2022) Phenotype of Chronic Obstructive Pulmonary Disease Based on Computed Tomography–Defined Underlying Pathology. Tuberculosis and Respiratory Diseases 85:4, pages 302-312.
Crossref
Rui Lv, Mengyao Xie, Huaqian Jin, Pingping Shu, Mingli Ouyang, Yanmao Wang, Dan Yao, Lehe Yang, Xiaoying Huang & Yiran Wang. (2022) A Preliminary Study on the Relationship Between High-Resolution Computed Tomography and Pulmonary Function in People at Risk of Developing Chronic Obstructive Pulmonary Disease. Frontiers in Medicine 9.
Crossref
Pradeesh Sivapalan, Andras Bikov, Charlotte Suppli Ulrik, Therese Sophie Lapperre, Alexander G. Mathioudakis, Mats Christian Højberg Lassen, Kristoffer Grundtvig Skaarup, Tor Biering-Sørensen, Jørgen Vestbo & Jens-Ulrik S. Jensen. (2021) Corticosteroid Resistance in Smokers—A Substudy Analysis of the CORTICO-COP Randomised Controlled Trial. Journal of Clinical Medicine 10:12, pages 2734.
Crossref
Hannah R. Whittaker, Debbie Jarvis, Mohamed R. Sheikh, Steven J. Kiddle & Jennifer K. Quint. (2019) Inhaled corticosteroids and FEV1 decline in chronic obstructive pulmonary disease: a systematic review. Respiratory Research 20:1.
Crossref
Charlotte Suppli Ulrik. (2017) Late-Onset Asthma: A Diagnostic and Management Challenge. Drugs & Aging 34:3, pages 157-162.
Crossref
Diana Crossley, Alice Turner & Deepak Subramanian. (2017) Phenotyping emphysema and airways disease: Clinical value of quantitative radiological techniques. World Journal of Respirology 7:1, pages 1.
Crossref
Masayuki Itoh. 2017. Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease 245 266 .
T. Chinet, J. Dumoulin, I. Honore, J.-M. Braun, L.-J. Couderc, M. Febvre, G. Mangiapan, C. Maurer, P. Serrier, F. Soyez, P. Terrioux & G. Jebrak. (2016) Place des corticostéroïdes inhalés dans la BPCO. Revue des Maladies Respiratoires 33:10, pages 877-891.
Crossref
David A Scott, Bethan Woods, Juliette C Thompson, James F Clark, Neil Hawkins, Mike Chambers, Bartolome R. Celli & Peter Calverley. (2015) Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysis. BMC Pulmonary Medicine 15:1.
Crossref
Surya P Bhatt, George R Washko, Mark T Dransfield, Jessica C Sieren, John D NewellJrJr & Eric A Hoffman. (2014) Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction: authors’ response. Thorax 69:12, pages 1147-1148.
Crossref
K. Suresh Babu, Jack A. Kastelik & Jaymin B. Morjaria. (2014) Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective. British Journal of Clinical Pharmacology 78:2, pages 282-300.
Crossref
Yaa-Hui Dong, Chia-Hsuin Chang, Fe-Lin Lin Wu, Li-Jiuan Shen, Peter M.A. Calverley, Claes-Göran Löfdahl, Mei-Shu Lai & Donald A. Mahler. (2014) Use of Inhaled Corticosteroids in Patients With COPD and the Risk of TB and Influenza. Chest 145:6, pages 1286-1297.
Crossref
Kayleigh M Kew, Sofia Dias & Christopher J Cates. (2014) Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. Cochrane Database of Systematic Reviews.
Crossref
Kayleigh M Kew & Alieksei Seniukovich. (2014) Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2014:12.
Crossref
Luis Javier Nannini, Phillippa Poole, Stephen J Milan, Rebecca Holmes & Rebecca Normansell. (2013) Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease . Cochrane Database of Systematic Reviews 2018:3.
Crossref
Luis Javier Nannini, Phillippa Poole, Stephen J Milan & Annabel Kesterton. (2013) Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease . Cochrane Database of Systematic Reviews 2014:6.
Crossref
Abdullah Sayiner, Cameron Hague, Amr Ajlan, Jonathon Leipsic, Lauren Wierenga, Natasha M. Krowchuk, Naim Ceylan, Arzu Sayiner, Don D. Sin & Harvey O. Coxson. (2013) Bronchiolitis in young female smokers. Respiratory Medicine 107:5, pages 732-738.
Crossref
Hans-Ulrich Kauczor, Claus Peter Heussel & Felix JF Herth. (2013) Longitudinal quantitative low-dose CT in COPD: ready for use?. The Lancet Respiratory Medicine 1:2, pages 95-96.
Crossref
Ian A Yang, Melissa S Clarke, Esther HA Sim & Kwun M Fong. (2012) Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2016:8.
Crossref
GEORGE R. WASHKO, GRACE PARRAGA & HARVEY O. COXSON. (2012) Quantitative pulmonary imaging using computed tomography and magnetic resonance imaging. Respirology 17:3, pages 432-444.
Crossref
Gaël Dournes, Michel Montaudon, Patrick Berger & François Laurent. (2012) In Vivo Computed Tomography as a Research Tool to Investigate Asthma and COPD: Where Do We Stand?. Journal of Allergy 2012, pages 1-11.
Crossref
Krisztina Gál, Áron Cseh, Balázs Szalay, Krisztina Rusai, Ádám Vannay, József Lukácsovits, Uwe Heemann, Attila J. Szabó, György Losonczy, Lilla Tamási & Veronika Müller. (2010) Effect of cigarette smoke and dexamethasone on Hsp72 system of alveolar epithelial cells. Cell Stress and Chaperones 16:4, pages 369-378.
Crossref
Marina Miller, Jae Youn Cho, Alexa Pham, Paul J. Friedman, Joe Ramsdell & David H. Broide. (2011) Persistent Airway Inflammation and Emphysema Progression on CT Scan in Ex-Smokers Observed for 4 Years. Chest 139:6, pages 1380-1387.
Crossref
Craig P Hersh. (2010) Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities. Pharmacogenomics 11:2, pages 237-247.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.